Table 1.
Feature | Experimental Group (n = 24) | Control Group (n = 18) | p= |
---|---|---|---|
M-NCD etiology, n | |||
Vascular | 11 | 4 | 0.41 a |
Alzheimer | 8 | 7 | |
Fronto-temporal | 2 | 3 | |
Other | 3 | 4 | |
M-NCD severity level, n | |||
MMSE < 18 | 6 | 6 | 0.54 a |
MMSE 18–23 | 16 | 10 | |
MMSE > 23 | 2 | 2 | |
Gender, M/F, n | 13/11 | 6/12 | 0.18 a |
Chronological age, years * | 68.5 (61.8/72.1) | 64.0 (61.3/69.8) | 0.28 b |
Education, years * | 8.0 (5.0/11.0) | 8.0 (5.0/13.0) | 0.47 b |
Mini Mental State Examination c * | 20.1 (18.0/21.9) | 19.6 (15.6/20.5) | 0.19 b |
Coloured Progressive Matricesc * | 20.1 (18.1/24.3) | 19.0 (14.4/24.3) | 0.47b |
Visuo-spatial span (Corsi’s test)c * | 4.3 (3.4/4.7) | 3.6 (2.6/4.1) | 0.19 b |
Digit Spanc * | 4.5 (3.5/4.9) | 4.1 (3.9/4.7) | 0.35 b |
Rey’s 15 words, Immediate Recallc * | 26.0 (22.3/28.7) | 21.3 (17.2/25.5) | 0.1 b |
Rey’s 15 words, Delayed Recallc * | 3.5 (2.5/5.4) | 2.0 (0.0/4.2) | 0.55 b |
Frontal Assessment Battery * | 9.5 (8.0/11.0) | 8.5 (6.0/11.0) | 0.75 b |
ADL * | 6.0 (4.0/6.0) | 6.0 (5.0/6.0) | 0.62 b |
IADL, % * | 37.5 (25.0/62.5) | 62.3 (50.0/62.5) | 0.3 b |
Information, correct responses * | 24.0 (21.0/26.3) | 24.0. (22.0/26.0) | 0.99 b |
Information, total time, s * | 264.5 (233.8/286.5) | 314 (245.5/367.3) | 0.04 |
Suitcase, correct responses * | 5.0 (3.0/7.3) | 5.0 (3.0/9.0) | 0.5 b |
Suitcase, total time, s * | 200.0 (128.0/263.8) | 214.0 (173.0/395.0) | 0.38 b |
Medicines, correct responses * | 6.5 (4.3/8.0) | 5 (3.5/6.5) | 0.31 b |
Medicines, total time, s * | 179.5 (156.3/230.5) | 261.5 (218.8/377.3) | 0.01 |
Supermarket, correct responses * | 10.0 (7.0/13.0) | 9.0 (5.0/12.0) | 0.56 b |
Supermarket, total time, s * | 270.0 (227.8/393.0) | 343.0 (284.5/370.5) | 0.52 b |
* Data reported as median (25–75th centile). M-NCD = major neurocognitive disorder; a Chi square test; b Mann Whitney’s U test; c corrected scores (age/education).